| 41 | LLYOpen LLY on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | Eli Lilly and CompanyHealthcare·Drug Manufacturers - General | 94 | 66Quality: 66th percentile | 90Momentum: 90th percentile | 93Growth: 93rd percentile | 9Valuation: 9th percentile | 90Expectations: 90th percentile | QQuality66Quality: 66th percentileMMomentum90Momentum: 90th percentileGGrowth93Growth: 93rd percentileVValuation9Valuation: 9th percentileEExpectations90Expectations: 90th percentile |
| 133 | ABBVOpen ABBV on Seeking Alpha in a new tab.95% of the way from the 52-week low to the 52-week high. | AbbVieHealthcare·Drug Manufacturers - General | 81 | –No data | 89Momentum: 89th percentile | 77Growth: 77th percentile | 30Valuation: 30th percentile | 22Expectations: 22nd percentile | QQuality–No dataMMomentum89Momentum: 89th percentileGGrowth77Growth: 77th percentileVValuation30Valuation: 30th percentileEExpectations22Expectations: 22nd percentile |
| 184 | AMGNOpen AMGN on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high. | AmgenHealthcare·Drug Manufacturers - General | 74 | 60Quality: 60th percentile | 84Momentum: 84th percentile | 60Growth: 60th percentile | 35Valuation: 35th percentile | 71Expectations: 71st percentile | QQuality60Quality: 60th percentileMMomentum84Momentum: 84th percentileGGrowth60Growth: 60th percentileVValuation35Valuation: 35th percentileEExpectations71Expectations: 71st percentile |
| 291 | JNJOpen JNJ on Seeking Alpha in a new tab.88% of the way from the 52-week low to the 52-week high. | Johnson & JohnsonHealthcare·Drug Manufacturers - General | 59 | 46Quality: 46th percentile | 81Momentum: 81st percentile | 41Growth: 41st percentile | 35Valuation: 35th percentile | 31Expectations: 31st percentile | QQuality46Quality: 46th percentileMMomentum81Momentum: 81st percentileGGrowth41Growth: 41st percentileVValuation35Valuation: 35th percentileEExpectations31Expectations: 31st percentile |
| 296 | BMYOpen BMY on Seeking Alpha in a new tab.77% of the way from the 52-week low to the 52-week high. | Bristol-Myers SquibbHealthcare·Drug Manufacturers - General | 58 | 57Quality: 57th percentile | 70Momentum: 70th percentile | 24Growth: 24th percentile | 83Valuation: 83rd percentile | 89Expectations: 89th percentile | QQuality57Quality: 57th percentileMMomentum70Momentum: 70th percentileGGrowth24Growth: 24th percentileVValuation83Valuation: 83rd percentileEExpectations89Expectations: 89th percentile |
| 315 | MRKOpen MRK on Seeking Alpha in a new tab.81% of the way from the 52-week low to the 52-week high. | Merck & Co.Healthcare·Drug Manufacturers - General | 55 | 16Quality: 16th percentile | 90Momentum: 90th percentile | 7Growth: 7th percentile | 36Valuation: 36th percentile | 95Expectations: 95th percentile | QQuality16Quality: 16th percentileMMomentum90Momentum: 90th percentileGGrowth7Growth: 7th percentileVValuation36Valuation: 36th percentileEExpectations95Expectations: 95th percentile |
| 500 | BIIBOpen BIIB on Seeking Alpha in a new tab.99% of the way from the 52-week low to the 52-week high. | BiogenHealthcare·Drug Manufacturers - General | 29 | 15Quality: 15th percentile | 84Momentum: 84th percentile | 7Growth: 7th percentile | 69Valuation: 69th percentile | 85Expectations: 85th percentile | QQuality15Quality: 15th percentileMMomentum84Momentum: 84th percentileGGrowth7Growth: 7th percentileVValuation69Valuation: 69th percentileEExpectations85Expectations: 85th percentile |
| 556 | GILDOpen GILD on Seeking Alpha in a new tab.97% of the way from the 52-week low to the 52-week high. | Gilead SciencesHealthcare·Drug Manufacturers - General | 21 | 17Quality: 17th percentile | 80Momentum: 80th percentile | 8Growth: 8th percentile | 31Valuation: 31st percentile | 56Expectations: 56th percentile | QQuality17Quality: 17th percentileMMomentum80Momentum: 80th percentileGGrowth8Growth: 8th percentileVValuation31Valuation: 31st percentileEExpectations56Expectations: 56th percentile |
| 558 | PFEOpen PFE on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high. | PfizerHealthcare·Drug Manufacturers - General | 21 | –No data | 72Momentum: 72nd percentile | 1Growth: 1st percentile | 90Valuation: 90th percentile | 73Expectations: 73rd percentile | QQuality–No dataMMomentum72Momentum: 72nd percentileGGrowth1Growth: 1st percentileVValuation90Valuation: 90th percentileEExpectations73Expectations: 73rd percentile |
| 615 | NVOOpen NVO on Seeking Alpha in a new tab.17% of the way from the 52-week low to the 52-week high. | Novo Nordisk A/SHealthcare·Drug Manufacturers - General | 12 | 20Quality: 20th percentile | 34Momentum: 34th percentile | 11Growth: 11th percentile | 77Valuation: 77th percentile | 80Expectations: 80th percentile | QQuality20Quality: 20th percentileMMomentum34Momentum: 34th percentileGGrowth11Growth: 11th percentileVValuation77Valuation: 77th percentileEExpectations80Expectations: 80th percentile |